{"filing":{"accession_number":"0001193125-26-259532","cik":"0001770121","ticker":"SANA","company_name":"Sana Biotechnology, Inc.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"sana-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1770121/000119312526259532/sana-20260604.htm"},"events":[{"id":6490,"run_id":5678,"accession_number":"0001193125-26-259532","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Sana Biotechnology's 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.) and (2) ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (For, Against/Withheld, Abstain, and Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 shareholder vote results disclosures.","company_name":"Sana Biotechnology, Inc.","ticker":"SANA","filing_date":"2026-06-05","form":"8-K","submitted_at":null,"items":[{"id":4753,"accession_number":"0001193125-26-259532","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Sana Biotechnology's 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.) and (2) ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (For, Against/Withheld, Abstain, and Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:06:25.960767+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4753,"accession_number":"0001193125-26-259532","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Sana Biotechnology's 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.) and (2) ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (For, Against/Withheld, Abstain, and Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:06:25.960767+00:00","company_name":"Sana Biotechnology, Inc.","ticker":"SANA","filing_date":"2026-06-05"}]}